Clinical correlates of cannabis use among adolescent psychiatric inpatients

European Psychiatry

Volumn 27, Issue 6, 2012, Pages 470-475

  Lev Ran, S ^a,b   Aviram, A ^c   Braw, Y ^a,d   Nitzan, U ^a,b   Ratzoni, G ^a,b   Fennig, S ^a,b  

^a SHALVATA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d ARIEL UNIVERSITY   (Israel)

Author keywords

Adolescent; Cannabis; Clinical correlates; Inpatient

Indexed keywords

CANNABIS; MOOD STABILIZER; NEUROLEPTIC AGENT;

ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS USE; DISRUPTIVE BEHAVIOR; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH CENTER; MENTAL PATIENT; MOOD DISORDER; PRIORITY JOURNAL;

ADOLESCENT; ALCOHOLISM; CHILD; FEMALE; HUMANS; INPATIENTS; ISRAEL; MALE; MARIJUANA ABUSE; MENTAL DISORDERS; PREVALENCE; YOUNG ADULT;

EID: 84863875717     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.11.002     Document Type: Article

References (67)

1. Amaladoss A., Roberts N., Amaladoss F. Evidence for use of mood stabilizers and anticonvulsants in the treatment of nonaffective disorders in children and adolescents. Clin Neuropharmacol 2010, 33(6):303-311.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders, Fourth edition, Text Revision (DSM-IV-TR). 2000, American Psychiatric Association, Washington, DC.
3. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325(7374):1212-1213.
4. Bar Hamburger R., Ezrahi Y., Roziner I., Nirel R. Psychoactive substance use in Israel 2009, The Israel Anti-Drug Agency, Jerusalem.
5. Bloch Y., Levcovitch Y., Bloch A.M., Mendlovic S., Ratzoni G. Electroconvulsive therapy in adolescents: similarities to and differences from adults. J Am Acad Child Adolesc Psychiatry 2001, 40(11):1332-1336.
6. Bloch Y., Mendlovic S., Strupinsky S., Altshuler A., Fennig S., Ratzoni G. Injections of depot antipsychotic medications in patients suffering from schizophrenia: do they hurt?. J Clin Psychiatry 2001, 62(11):855-859.
7. Bovasso G.B. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001, 158(12):2033-2037.
8. Brook J.S., Cohen P., Brook D.W. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 1998, 37(3):322-330.
9. Brook D.W., Brook J.S., Zhang C., Cohen P., Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 2002, 59(11):1039-1044.
10. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005, 57(10):1117-1127.
11. Creemers H.E., van Lier P.A., Vollebergh W.A., Ormel J., Verhulst F.C., Huizink A.C. Predicting onset of cannabis use in early adolescence: the interrelation between high-intensity pleasure and disruptive behavior. The TRAILS study. J Stud Alcohol Drugs 2009, 70(6):850-858.
12. Danielson C.K., Overholser J.C., Butt Z.A. Association of substance abuse and depression among adolescent psychiatric inpatients. Can J Psychiatry 2003, 48(11):762-765.
13. Daudin M., Cohen D., Edel Y., Bonnet N., Bodeau N., Consoli A., et al. Psychosocial and clinical correlates of substance use disorder in an adolescent inpatient psychiatric population. J Can Acad Child Adolesc Psychiatry 2010, 19(4):264-273.
14. Earleywine M., Newcomb M.D. Concurrent versus simultaneous polydrug use: prevalence, correlates, discriminant validity, and prospective effects on health outcomes. Exp Clin Psychopharmacol 1997, 5(4):353-364.
15. Esposito-Smythers C., Spirito A. Adolescent substance use and suicidal behavior: a review with implications for treatment research. Alcohol Clin Exp Res 2004, 28(5 Suppl.):77S-88S.
16. European Monitoring Center for drugs and drug addiction. The state of the drugs problem in the accending and candidate countries to the European Union and Norway: annual reports. Luxembourg, Office of the Official Publications of the European Communities 2006.
17. Fergusson D.M., Horwood L.J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97(9):1123-1135.
18. Fergusson D.M., Horwood L.J., Ridder E.M. Conduct and attentional problems in childhood and adolescence and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug Alcohol Depend 2007, 88(Suppl. 1):S14-S26.
19. Findling R.L. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents. J Clin Psychiatry 2008, 69(Suppl. 4):9-14.
20. Findling R.L., Steiner H., Weller E.B. Use of antipsychotics in children and adolescents. J Clin Psychiatry 2005, 66(Suppl. 7):29-40.
21. Flory K., Lynam D.R. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?. Clin Child Fam Psychol Rev 2003, 6(1):1-16.
22. Forman E.M., Berk M.S., Henriques G.R., Brown G.K., Beck A.T. History of multiple suicide attempts as a behavioral marker of severe psychopathology. Am J Psychiatry 2004, 161(3):437-443.
23. Foti D.J., Kotov R., Guey L.T., Bromet E.J. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am J Psychiatry 2010, 167(8):987-993.
24. Gilat Y., Ben-Dor D.H., Magen A., Wolovick L., Vekslerchik M., Weizman A., et al. Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: a 10 years retrospective analysis. Eur Psychiatry 2011, 26(4):265-269.
25. Goodman A. Substance use and common child mental health problems: examining longitudinal associations in a British sample. Addiction 2010, 105(8):1484-1496.
26. Grella C.E., Hser Y.I., Joshi V., Rounds-Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis 2001, 189(6):384-392.
27. Griffith-Lendering M.F., Huijbregts S.C., Mooijaart A., Vollebergh W.A., Swaab H. Cannabis use and development of externalizing and internalizing behaviour problems in early adolescence: a TRAILS study. Drug Alcohol Depend 2010, 116(1-3):11-17.
28. Grilo C.M., Becker D.F., Walker M.L., Levy K.N., Edell W.S., McGlashan T.H. Psychiatric comorbidity in adolescent inpatients with substance use disorders. J Am Acad Child Adolesc Psychiatry 1995, 34(8):1085-1091.
29. Grilo C.M., Becker D.F., Fehon D.C., Edell W.S., McGlashan T.H. Conduct disorder, substance use disorders, and coexisting conduct and substance use disorders in adolescent inpatients. Am J Psychiatry 1996, 153(7):914-920.
30. Hazell P. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder. Australas Psychiatry 2010, 18(6):556-559.
31. Hides L., Dawe S., Kavanagh D.J., Young R.M. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. Br J Psychiatry 2006, 189:137-143.
32. James A.C., Crow T.J., Renowden S., Wardell A.M., Smith D.M., Anslow P. Is the course of brain development in schizophrenia delayed? Evidence from onsets in adolescence. Schizophr Res 1999, 40(1):1-10.
33. Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001, 178:116-212.
34. Johnson L., O'Mailey P., Bachman J., Ahalenberg I. Monitoring the future national survey results on drug use 1975-2005: volume 1, Secondary school students. 2006, NIH Publication No-06-5883. National Institute on drug abuse, Bethesda.
35. Kelly E., Darke S., Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev 2004, 23(3):319-344.
36. Latimer W., Zur J. Epidemiologic trends of adolescent use of alcohol, tobacco, and other drugs. Child Adolesc Psychiatr Clin N Am 2010, 19(3):451-464.
37. Licanin I., Music E., Laslo E., Berg-Kelly K., Masic I., Redzic A., et al. Suicidal thoughts related to psychoactive substance abuse among adolescents. Med Arh 2003, 57(4):237-240.
38. Lynskey M., Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000, 95(11):1621-1630.
39. Malone D.T., Hill M.N., Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol 2010, 160(3):511-522.
40. McGee R., Williams S., Poulton R., Moffitt T. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 2000, 95(4):491-503.
41. McKay J.R., Murphy R.T., Rivinus T.R., Maisto S.A. Family dysfunction and alcohol and drug use in adolescent psychiatric inpatients. J Am Acad Child Adolesc Psychiatry 1991, 30(6):967-972.
42. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
43. Niethammer O., Frank R. Prevalence of use, abuse and dependence on legal and illegal psychotropic substances in an adolescent inpatient psychiatric population. Eur Child Adolesc Psychiatry 2007, 16(4):254-259.
44. Olfson M., Blanco C., Liu L., Moreno C., Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006, 63(6):679-685.
45. Pape H., Rossow I., Storvoll E.E. Under double influence: assessment of simultaneous alcohol and cannabis use in general youth populations. Drug Alcohol Depend 2009, 101(1-2):69-73.
46. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002, 325(7374):1195-1198.
47. Perrone J., De Roos F., Jayaraman S., Hollander J.E. Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med 2001, 19(1):49-51.
48. Ramaekers J.G., Robbe H.W., O'Hanlon J.F. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 2000, 15(7):551-558.
49. Ramaekers J.G., Berghaus G., van Laar M., Drummer O.H. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004, 73(2):109-119.
50. Rasmussen H.B., Timm S., Wang A.G., Soeby K., Lublin H., Fenger M., et al. Association between the CCR5 32-bp deletion allele and late onset of schizophrenia. Am J Psychiatry 2006, 163(3):507-511.
51. Rey J.M., Martin A., Krabman P. Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years. J Am Acad Child Adolesc Psychiatry 2004, 43(10):1194-1205.
52. Roberts R.E., Roberts C.R., Xing Y. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey. Drug Alcohol Depend 2007, 88(Suppl. 1):S4-S13.
53. Scourfield J., Stevens D.E., Merikangas K.R. Substance abuse, comorbidity, and sensation seeking: gender differences. Compr Psychiatry 1996, 37(6):384-392.
54. Semple D.M., McIntosh A.M., Lawrie S.M. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005, 19(2):187-194.
55. Shoval G., Zalsman G., Apter A., Diller R., Sher L., Weizman A. A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use. Compr Psychiatry 2007, 48(1):1-7.
56. Shrier L.A., Harris S.K., Kurland M., Knight J.R. Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics 2003, 111(6 Pt 1):e699-e705.
57. Stepp S.D., Burke J.D., Hipwell A.E., Loeber R. Trajectories of Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder Symptoms as Precursors of Borderline Personality Disorder Symptoms in Adolescent Girls. J Abnorm Child Psychol 2011, Epub ahead of print. 10.1007/s10802-011-9530-6.
58. Stoker A., Swadi H. Perceived family relationships in drug abusing adolescents. Drug Alcohol Depend 1990, 25(3):293-297.
59. Swadi H. Individual risk factors for adolescent substance use. Drug Alcohol Depend 1999, 55(3):209-224.
60. Swadi H., Bobier C. Substance use disorder comorbidity among inpatient youths with psychiatric disorder. Aust N Z J Psychiatry 2003, 37(3):294-298.
61. Teichman M., Rahav G. The annual survey of substance use in Israel 2003, The Israel Anti-Drug Agency, Jerusalem.
62. Turgay A. Psychopharmacological treatment of oppositional defiant disorder. CNS Drugs 2009, 23(1):1-17.
63. Van Bockstaele E.J., Reyes B.A., Valentino R.J. The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res 2010, 1314:162-174.
64. Van Dam N.T., Earleywine M., DiGiacomo G. Polydrug use, cannabis, and psychosis-like symptoms. Hum Psychopharmacol 2008, 23(6):475-485.
65. Verstraete A.G. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 2004, 26(2):200-205.
66. Weaver M.F., Dupre M.A., Cropsey K.L., Koch J.R., Sood B.A., Wiley J.L., et al. Addiction epidemiology in adolescents receiving inpatient psychiatric treatment. Addict Behav 2007, 32(12):3107-3113.
67. Wittchen H.U., Frohlich C., Behrendt S., Gunther A., Rehm J., Zimmermann P., et al. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007, 88(Suppl. 1):S60-S70.